Congenital Hypothyroidism in Newborns: Current Approaches to Diagnosis and Treatment

Congenital hypothyroidism is a deficiency of thyroid hormone present at birth. Clinical signs are often subtle in the neonatal period, although prolonged hormone deficiency can impair brain development. This narrative review examines newborn screening, diagnostic confirmation, and early treatment. Dried blood spot screening based on thyroid-stimulating hormone (TSH) identifies most cases of primary congenital hypothyroidism. An abnormal screening result requires prompt measurement of serum TSH and free thyroxine (FT4), interpreted using age-specific reference intervals. Two diagnostic challenges deserve particular attention. Preterm or critically ill newborns may have a delayed TSH rise, while infants with central hypothyroidism may have low FT4 without a marked TSH elevation. For infants with confirmed primary congenital hypothyroidism, oral levothyroxine is the treatment of choice and should begin as soon as possible, ideally within the first two weeks of life. Thyroid imaging can clarify the underlying cause and should not delay treatment. Follow-up combines serial thyroid function testing with assessment of growth and neurodevelopment. The benefit of newborn screening depends on timely confirmation, prompt treatment, and sustained biochemical control throughout early childhood.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-19
DOI
https://doi.org/10.5281/zenodo.24363669
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Congenital Hypothyroidism in Newborns: Current Approaches to Diagnosis and Treatment

Khursanoy Zakirovna Djuraeva
Zenodo (CERN European Organization for Nuclear Research)
Thyroid Disorders and Treatments
article

Congenital Hypothyroidism in Newborns: Current Approaches to Diagnosis and Treatment

Khursanoy Zakirovna Djuraeva
article en

Abstract

Congenital hypothyroidism is a deficiency of thyroid hormone present at birth. Clinical signs are often subtle in the neonatal period, although prolonged hormone deficiency can impair brain development. This narrative review examines newborn screening, diagnostic confirmation, and early treatment. Dried blood spot screening based on thyroid-stimulating hormone (TSH) identifies most cases of primary congenital hypothyroidism. An abnormal screening result requires prompt measurement of serum TSH and free thyroxine (FT4), interpreted using age-specific reference intervals. Two diagnostic challenges deserve particular attention. Preterm or critically ill newborns may have a delayed TSH rise, while infants with central hypothyroidism may have low FT4 without a marked TSH elevation. For infants with confirmed primary congenital hypothyroidism, oral levothyroxine is the treatment of choice and should begin as soon as possible, ideally within the first two weeks of life. Thyroid imaging can clarify the underlying cause and should not delay treatment. Follow-up combines serial thyroid function testing with assessment of growth and neurodevelopment. The benefit of newborn screening depends on timely confirmation, prompt treatment, and sustained biochemical control throughout early childhood.

Zenodo (CERN European Organization for Nuclear Research)
Andijan State Medical Institute (UZ)
Thyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon